One drug, five targets.

Cell Research · 1 Oct 2026 · Journal Article · Open access

Fu, Saltiel

The abstract is read at the publisher; the summary is JClub's.

There's no AI summary of this paper here yet.

Open access

Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.

Harnessing PPAR pharmacology through dual incretin-directed delivery.
Cell Metabolism · 2 June 2026 · Comment
AI summary · may contain errors
A unimolecular conjugate was engineered to act as a quintuple agonist, combining GLP-1R/GIPR co-agonism with pan-PPAR activation to link incretin signaling to PPAR transcriptional control.
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42102815
Open in JClub

Journals this month

bioRxiv6399
medRxiv1720
PNAS508
Sci Adv379
JAMA333
Cell Rep302
Environ Pollution234
Environ Res217
BMJ214
Nat Commun190
Science185
NEJM170
Plant Cell Environ169
New Phytol157
NAR157
EHJ154
Lancet151
Curr Biol129

All journals →

Topics moving, week to 13 Nov 2026

Single-cell and spatial transcriptomics8
CAR-T cell therapy research7
CRISPR and Genetic Engineering6
Lung Cancer Treatments and Mutations4
Pancreatic and Hepatic Oncology Research4
Gut microbiota and health4
Lipoproteins and Cardiovascular Health3
Genomics and Phylogenetic Studies3
Inflammatory Bowel Disease3
RNA and protein synthesis mechanisms3

All topics →

By field

General Science & Medicine19
Clinical Medicine18
Cell & Molecular Biology21
Immunology & Inflammation5
Neuroscience7
Genomics & Bioinformatics21
Microbiology & Mycology23
Oncology9
Protected Cropping & Horticultural Science4
Plant Physiology & Photobiology12
Student Research1

All journals by field →

One drug, five targets.

Related in JClub

Harnessing PPAR pharmacology through dual incretin-directed delivery.

Browse JClub